Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-047102
Filing Date
2024-11-12
Accepted
2024-11-12 16:02:33
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgmo-20240930.htm   iXBRL 10-Q 1185815
2 EX-10.1 sgmo-20240930xex101.htm EX-10.1 608753
3 EX-10.2 thirdamendmenttoleaseagr.htm EX-10.2 6798
4 EX-31.1 sgmo-20240930xex311.htm EX-31.1 10023
5 EX-31.2 sgmo-20240930xex312.htm EX-31.2 10138
6 EX-32.1 sgmo-20240930xex321.htm EX-32.1 7142
12 GRAPHIC thirdamendmenttoleaseagr001.jpg GRAPHIC 239297
13 GRAPHIC thirdamendmenttoleaseagr002.jpg GRAPHIC 160693
14 GRAPHIC thirdamendmenttoleaseagr003.jpg GRAPHIC 61638
  Complete submission text file 0001628280-24-047102.txt   7445582

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20240930.xsd EX-101.SCH 41724
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20240930_cal.xml EX-101.CAL 62345
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20240930_def.xml EX-101.DEF 208536
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20240930_lab.xml EX-101.LAB 464976
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20240930_pre.xml EX-101.PRE 341214
68 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20240930_htm.xml XML 870999
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 241447827
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)